首页> 外文会议>Asian Symposium on Biomedical Materials >An Implantable Immunosuppressive Cyclosporine Drug Delivery System
【24h】

An Implantable Immunosuppressive Cyclosporine Drug Delivery System

机译:一种可植入免疫抑制环孢菌素药物递送系统

获取原文

摘要

In the article a kind biodegradable drug carrier (glycolide-co-lactide-co-caprolactone) tricomponent copolymer (PGLC) was synthesized by ring opening copolymerization of glycolide (GA), lactide (LA) and s-caprolactone (CL), and was used to manufacture an implantable drug preparation-Cyclosporine-PGLC drug delivery system (Cs-PGLC DDS). The Cs could slowly release from the Cs-PGLC DDS near linearly and last for a long time in vitro. A clinically significant Cs concentration in the cornea and anterior chamber could be achieved by implanting the Cs-PGLC DDS in anterior chamber. It was demonstrated that the Cs-PGLC DDS is a long-effective intraocular immunosuppressive agent for remaining corneal allograft clear and significantly prolong its survival time.
机译:在制品中,通过乙酰胺(Ga),丙交酯(La)和S-己内酯(Cl)的开环共聚合成了一种可生物降解的药物载体(乙酰胺 - 共聚物 - 共聚物)三丙二醇共聚物(PGLC)。用于制造可植入的药物制剂 - 环孢菌素-PGLC药物递送系统(CS-PGLC DDS)。 CS可以从CS-PGLC DDS慢慢释放,并在体外持续很长时间。可以通过将CS-PGLC DDS植入前房中的CS-PGLC DD来实现角膜和前腔中的临床上显着的CS浓度。结果证明CS-PGLC DDS是一种长效的眼内免疫抑制剂,可澄清角膜异种移植物,显着延长其存活时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号